Cargando…

Targeted cyclooxygenase-2 inhibiting nanomedicine results in pain-relief and differential expression of the RNA transcriptome in the dorsal root ganglia of injured male rats

Chronic constriction injury of the sciatic nerve in rats causes peripheral neuropathy leading to pain-like behaviors commonly seen in humans. Neuropathy is a leading cause of neuropathic pain, which involves a complex cellular and molecular response in the peripheral nervous system with interactions...

Descripción completa

Detalles Bibliográficos
Autores principales: Stevens, Andrea M, Saleem, Muzamil, Deal, Brooke, Janjic, Jelena, Pollock, John A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7543154/
https://www.ncbi.nlm.nih.gov/pubmed/32762277
http://dx.doi.org/10.1177/1744806920943309
_version_ 1783591679760007168
author Stevens, Andrea M
Saleem, Muzamil
Deal, Brooke
Janjic, Jelena
Pollock, John A
author_facet Stevens, Andrea M
Saleem, Muzamil
Deal, Brooke
Janjic, Jelena
Pollock, John A
author_sort Stevens, Andrea M
collection PubMed
description Chronic constriction injury of the sciatic nerve in rats causes peripheral neuropathy leading to pain-like behaviors commonly seen in humans. Neuropathy is a leading cause of neuropathic pain, which involves a complex cellular and molecular response in the peripheral nervous system with interactions between neurons, glia, and infiltrating immune cells. In this study, we utilize a nonsteroidal anti-inflammatory drug -loaded nanoemulsion to deliver the cyclooxygenase-2 inhibitor, Celecoxib, directly to circulating monocytes following nerve injury, which provides long-lasting pain relief. However, it is not fully understood how cyclooxygenase-2 inhibition in a macrophage traveling to the site of injury impacts gene expression in the dorsal root ganglia. To elucidate aspects of the molecular mechanisms underlying pain-like behavior in chronic constriction injury, as well as subsequent pain relief with treatment, we employ RNAseq transcriptome profiling of the dorsal root ganglia associated with the injured sciatic nerve in rats. Using high throughput RNA sequencing in this way provides insight into the molecular mechanisms involved in this neuroinflammatory response. We compare the transcriptome from the dorsal root ganglias of the following study groups: chronic constriction injury animals administered with cyclooxygenase-2 inhibiting celecoxib-loaded nanoemulsion, chronic constriction injury animals administered with vehicle treatment, a drug-free nanoemulsion, and a group of naïve, unoperated and untreated rats. The results show an extensive differential expression of 115 genes. Using the protein annotation through evolutionary relationship classification system, we have revealed pain-related signaling pathways and underlying biological mechanisms involved in the neuroinflammatory response. Quantitative polymerase chain reaction validation confirms expression changes for several genes. This study shows that by directly inhibiting cyclooxygenase-2 activity in infiltrating macrophages at the injured sciatic nerve, there is an associated change in the transcriptome in the cell bodies of the dorsal root ganglia.
format Online
Article
Text
id pubmed-7543154
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher SAGE Publications
record_format MEDLINE/PubMed
spelling pubmed-75431542020-10-20 Targeted cyclooxygenase-2 inhibiting nanomedicine results in pain-relief and differential expression of the RNA transcriptome in the dorsal root ganglia of injured male rats Stevens, Andrea M Saleem, Muzamil Deal, Brooke Janjic, Jelena Pollock, John A Mol Pain Research Article Chronic constriction injury of the sciatic nerve in rats causes peripheral neuropathy leading to pain-like behaviors commonly seen in humans. Neuropathy is a leading cause of neuropathic pain, which involves a complex cellular and molecular response in the peripheral nervous system with interactions between neurons, glia, and infiltrating immune cells. In this study, we utilize a nonsteroidal anti-inflammatory drug -loaded nanoemulsion to deliver the cyclooxygenase-2 inhibitor, Celecoxib, directly to circulating monocytes following nerve injury, which provides long-lasting pain relief. However, it is not fully understood how cyclooxygenase-2 inhibition in a macrophage traveling to the site of injury impacts gene expression in the dorsal root ganglia. To elucidate aspects of the molecular mechanisms underlying pain-like behavior in chronic constriction injury, as well as subsequent pain relief with treatment, we employ RNAseq transcriptome profiling of the dorsal root ganglia associated with the injured sciatic nerve in rats. Using high throughput RNA sequencing in this way provides insight into the molecular mechanisms involved in this neuroinflammatory response. We compare the transcriptome from the dorsal root ganglias of the following study groups: chronic constriction injury animals administered with cyclooxygenase-2 inhibiting celecoxib-loaded nanoemulsion, chronic constriction injury animals administered with vehicle treatment, a drug-free nanoemulsion, and a group of naïve, unoperated and untreated rats. The results show an extensive differential expression of 115 genes. Using the protein annotation through evolutionary relationship classification system, we have revealed pain-related signaling pathways and underlying biological mechanisms involved in the neuroinflammatory response. Quantitative polymerase chain reaction validation confirms expression changes for several genes. This study shows that by directly inhibiting cyclooxygenase-2 activity in infiltrating macrophages at the injured sciatic nerve, there is an associated change in the transcriptome in the cell bodies of the dorsal root ganglia. SAGE Publications 2020-08-06 /pmc/articles/PMC7543154/ /pubmed/32762277 http://dx.doi.org/10.1177/1744806920943309 Text en © The Author(s) 2020 https://creativecommons.org/licenses/by-nc/4.0/ Creative Commons Non Commercial CC BY-NC: This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).
spellingShingle Research Article
Stevens, Andrea M
Saleem, Muzamil
Deal, Brooke
Janjic, Jelena
Pollock, John A
Targeted cyclooxygenase-2 inhibiting nanomedicine results in pain-relief and differential expression of the RNA transcriptome in the dorsal root ganglia of injured male rats
title Targeted cyclooxygenase-2 inhibiting nanomedicine results in pain-relief and differential expression of the RNA transcriptome in the dorsal root ganglia of injured male rats
title_full Targeted cyclooxygenase-2 inhibiting nanomedicine results in pain-relief and differential expression of the RNA transcriptome in the dorsal root ganglia of injured male rats
title_fullStr Targeted cyclooxygenase-2 inhibiting nanomedicine results in pain-relief and differential expression of the RNA transcriptome in the dorsal root ganglia of injured male rats
title_full_unstemmed Targeted cyclooxygenase-2 inhibiting nanomedicine results in pain-relief and differential expression of the RNA transcriptome in the dorsal root ganglia of injured male rats
title_short Targeted cyclooxygenase-2 inhibiting nanomedicine results in pain-relief and differential expression of the RNA transcriptome in the dorsal root ganglia of injured male rats
title_sort targeted cyclooxygenase-2 inhibiting nanomedicine results in pain-relief and differential expression of the rna transcriptome in the dorsal root ganglia of injured male rats
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7543154/
https://www.ncbi.nlm.nih.gov/pubmed/32762277
http://dx.doi.org/10.1177/1744806920943309
work_keys_str_mv AT stevensandream targetedcyclooxygenase2inhibitingnanomedicineresultsinpainreliefanddifferentialexpressionofthernatranscriptomeinthedorsalrootgangliaofinjuredmalerats
AT saleemmuzamil targetedcyclooxygenase2inhibitingnanomedicineresultsinpainreliefanddifferentialexpressionofthernatranscriptomeinthedorsalrootgangliaofinjuredmalerats
AT dealbrooke targetedcyclooxygenase2inhibitingnanomedicineresultsinpainreliefanddifferentialexpressionofthernatranscriptomeinthedorsalrootgangliaofinjuredmalerats
AT janjicjelena targetedcyclooxygenase2inhibitingnanomedicineresultsinpainreliefanddifferentialexpressionofthernatranscriptomeinthedorsalrootgangliaofinjuredmalerats
AT pollockjohna targetedcyclooxygenase2inhibitingnanomedicineresultsinpainreliefanddifferentialexpressionofthernatranscriptomeinthedorsalrootgangliaofinjuredmalerats